GW Pharmaceuticals plc (GWPH) Formed Bullish Multiple Top; Buyers Could Thrive

April 23, 2018 - By Richard Conner

The stock of GW Pharmaceuticals plc (GWPH) shows a multiple tops pattern with $143.10 target or 8.00 % above today’s $132.50 share price. The 6 months chart pattern indicates low risk for the $3.74B company. It was reported on Apr, 23 by If the $143.10 price target is reached, the company will be worth $298.96M more.
Multiple tops are chart patterns with decent performance in a bull market. The failure rate is higher but the average decline is reasonable. Back-tests of such patterns show that the break even failure rate is 10%, the average rise: 19%, the throwback rate: 61% and the percentage of stocks meeting their price targets: 40%.

The stock increased 0.05% or $0.07 during the last trading session, reaching $132.5. About 85,369 shares traded. GW Pharmaceuticals plc (NASDAQ:GWPH) has declined 9.18% since April 23, 2017 and is downtrending. It has underperformed by 20.73% the S&P500.

Analysts await GW Pharmaceuticals plc (NASDAQ:GWPH) to report earnings on May, 8. They expect $-2.28 EPS, down 34.12 % or $0.58 from last year’s $-1.7 per share. After $-2.43 actual EPS reported by GW Pharmaceuticals plc for the previous quarter, Wall Street now forecasts -6.17 % EPS growth.

GW Pharmaceuticals plc (NASDAQ:GWPH) Ratings Coverage

Among 5 analysts covering GW Pharma (NASDAQ:GWPH), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. GW Pharma had 11 analyst reports since October 26, 2017 according to SRatingsIntel. On Tuesday, April 17 the stock rating was maintained by Cantor Fitzgerald with “Buy”. The firm has “Buy” rating by Leerink Swann given on Tuesday, January 23. The firm earned “Buy” rating on Thursday, December 14 by Goldman Sachs. Cowen & Co maintained GW Pharmaceuticals plc (NASDAQ:GWPH) on Wednesday, April 18 with “Buy” rating. The stock of GW Pharmaceuticals plc (NASDAQ:GWPH) has “Buy” rating given on Tuesday, February 6 by Bank of America. Cowen & Co maintained the shares of GWPH in report on Thursday, October 26 with “Buy” rating. As per Tuesday, November 14, the company rating was maintained by Bank of America. Cantor Fitzgerald maintained GW Pharmaceuticals plc (NASDAQ:GWPH) on Monday, December 4 with “Buy” rating. The stock of GW Pharmaceuticals plc (NASDAQ:GWPH) earned “Buy” rating by Cantor Fitzgerald on Monday, February 5. The company was maintained on Thursday, December 28 by Leerink Swann.

GW Pharmaceuticals plc (NASDAQ:GWPH) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: